Cargando…
SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition
Emerging variants of SARS‐CoV‐2 and potential novel epidemic coronaviruses underline the importance of investigating various viral proteins as potential drug targets. The papain‐like protease of coronaviruses has been less explored than other viral proteins; however, its substantive role in viral re...
Autores principales: | Ullrich, Sven, Nitsche, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538446/ https://www.ncbi.nlm.nih.gov/pubmed/35993805 http://dx.doi.org/10.1002/cbic.202200327 |
Ejemplares similares
-
Crystal structure of SARS-CoV-2 papain-like protease
por: Gao, Xiaopan, et al.
Publicado: (2021) -
Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
por: Klemm, Theresa, et al.
Publicado: (2020) -
The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020) -
Deubiquitinating Activity of the SARS-CoV Papain-Like Protease
por: Barretto, Naina, et al.
Publicado: (2006) -
Parthenolide reveals an allosteric mode to inhibit the deISGylation activity of SARS-CoV‑2 papain-like protease: Parthenolide covalently inhibits papain-like protease
por: Zou, Zhihui, et al.
Publicado: (2022)